ArticleJournal of medicinal chemistry2010

A type-II kinase inhibitor capable of inhibiting the T315I "gatekeeper" mutant of Bcr-Abl.

Hwan Geun Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.